MADRIGAL PHARMACEUTICALS, INC. Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated March 18, 2024 (Filed With SEC on March 20, 2024)
- Underwriting Agreement, dated September 28, 2023 (Filed With SEC on October 2, 2023)
- Underwriting Agreement, dated December 10, 2019, by and among Madrigal Pharmaceuticals, Inc., the Selling Stockholders, and Goldman Sachs & Co. LLC (Filed With SEC on December 12, 2019)
- Underwriting Agreement, dated June 6, 2018, by and between Madrigal Pharmaceuticals, Inc, Goldman Sachs & Co. LLC as Representative of the Underwriters set forth therein, and the... (Filed With SEC on June 8, 2018)
- Underwriting Agreement, dated December 18, 2017, by and between Madrigal Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC as Representative of the Underwriters set forth therein (Filed With SEC on December 21, 2017)
- 22,000,000 Shares Synta Pharmaceuticals Corp. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 1, 2015)
- 14,000,000 Shares Synta Pharmaceuticals Corp. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 14, 2013)
- 7,000,000 Shares Synta Pharmaceuticals Corp. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 6, 2012)
- 5,555,556 Shares of CommonStock par value $0.0001 SYNTA PHARMACEUTICALS CORP. UNDERWRITING AGREEMENT (Filed With SEC on January 8, 2010)
